Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Update

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the recipient of a large growth in short interest in the month of June. As of June 15th, there was short interest totaling 16,116 shares, a growth of 2,312.6% from the May 31st total of 668 shares. Based on an average daily volume of 18,819 shares, the days-to-cover ratio is currently 0.9 days. Approximately 0.5% of the company’s stock are short sold.

Invesco Pharmaceuticals ETF Stock Performance

Invesco Pharmaceuticals ETF stock traded up $0.78 during midday trading on Thursday, reaching $115.68. The stock had a trading volume of 4,781 shares, compared to its average volume of 33,049. Invesco Pharmaceuticals ETF has a 1-year low of $79.47 and a 1-year high of $117.09. The stock has a market capitalization of $378.27 million, a P/E ratio of 15.59 and a beta of 0.46. The firm’s fifty day simple moving average is $108.51 and its 200-day simple moving average is $106.63.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in PJP. Fifth Third Bancorp bought a new stake in Invesco Pharmaceuticals ETF during the 1st quarter worth about $36,000. Global Assets Advisory LLC bought a new position in shares of Invesco Pharmaceuticals ETF in the 1st quarter valued at about $42,000. IFP Advisors Inc grew its holdings in shares of Invesco Pharmaceuticals ETF by 31.3% in the 4th quarter. IFP Advisors Inc now owns 440 shares of the company’s stock valued at $46,000 after acquiring an additional 105 shares in the last quarter. International Assets Investment Management LLC bought a new position in shares of Invesco Pharmaceuticals ETF in the 4th quarter valued at about $64,000. Finally, Rockefeller Capital Management L.P. increased its position in shares of Invesco Pharmaceuticals ETF by 20.5% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock valued at $129,000 after acquiring an additional 209 shares during the last quarter.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.